sun pharma reports a largely in-line set of q4 numbers; us sales come in at $430 m | cnbc tv18
Published 1 year ago • 1.8K plays • Length 6:39
Download video MP4
Download video MP3
Similar videos
-
1:25
sun pharma q1fy25: net profit, ebitda, margin beat est; us formulation sales at $466 m | cnbc tv18
-
1:47
sun pharma q4 preview: strong growth in specialty biz likely to boost q4 performance | cnbc tv18
-
4:39
fed shifting to dual-mandate of the labor market and inflation, says allianz's mohamed el-erian
-
0:30
sales decline in q4 is a reflection of the pricing pressure in the us generic market: sun pharma
-
7:16
watch cnbc tv18 live | sun pharma beats the street with ₹1,984 crore net profit in q4fy23
-
3:52
signals have shown the market has really shift since the summer: alphasimplex's kathryn kaminski
-
6:19
big tech is your flight to safety and flight to growth, says constellation research's ray wang
-
5:25
tech has really lost its grip on this market, says strategas' chris verrone
-
1:55
sun pharma mohali unit: u.s. fda flags compliance concerns | halftime report | cnbc-tv18
-
1:00
us fda on sun pharma’s dadra unit: failed to clean, maintain, sanitise equipment at apt intervals
-
1:09
sp tulsian on sun pharma | keeping a positive call on it | cnbc-tv18
-
1:33
q4fy24 results: clsa downgrades sun pharma to underperform; nomura neutral on gland pharma
-
3:03
sun pharma dadra unit: us fda warning letter shows multiple repeat observations | n18v | cnbc tv18
-
1:13
sun pharma's subsidiary taro pharma reports good q3 earnings with margin at 10.8% | cnbc tv18
-
2:17
sun pharma q4: revenue at ₹11,983 cr, misses est, net profit above est at ₹2,654.5 cr | cnbc tv18
-
10:07
sun pharma's cs muralidharan on q4 results, taro acquisition plans & fy24 outlook | halftime report
-
1:23
#earningsminute: sun pharma misses street estimates this q4
-
2:51
decoding key triggers for pharma stocks as it outperform the nifty this week | cnbc-tv18
-
1:23
sun pharma is a buying opportunity and you must keep it: sudarshan sukhani | cnbc tv18
-
1:47
#earningsminute sun pharma registers steady q1
-
2:47
not aware of any whistleblower complaint : sun pharma on misgovernance allegations
-
0:54
sun pharma announces outcome of phase-1 obesity trial of gl0034 (utreglutide) | cnbc tv18
Clip.africa.com - Privacy-policy